Stay updated with breaking news from 21976u10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald acquired 1,567,515 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were purchased at an average cost of $1.70 per share, for a total transaction of $2,664,775.50. Following the completion of the acquisition, the chief executive officer […]
StockNews.com started coverage on shares of Fortress Biotech (NASDAQ:FBIO – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and set a $75.00 price target on shares of Fortress Biotech in a research report on Tuesday, August […]
StockNews.com began coverage on shares of Fortress Biotech (NASDAQ:FBIO – Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald reiterated an overweight rating and set a $5.00 price objective on shares of Fortress Biotech in a research note on […]
StockNews.com began coverage on shares of Fortress Biotech (NASDAQ:FBIO – Free Report) in a research note published on Tuesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald reissued an overweight rating and issued a $5.00 target price on shares of Fortress Biotech in a research note on Tuesday, August […]
Investment analysts at StockNews.com started coverage on shares of Fortress Biotech (NASDAQ:FBIO – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald reiterated an “overweight” rating and set a $5.00 price objective on shares of Fortress […]